Targeted prostate biopsy and MR-guided therapy for prostate cancer

Prostate cancer is the most commonly diagnosed noncutaneous cancer and second-leading cause of death in men. Many patients with clinically organ-confined prostate cancer undergo definitive treatment of the whole gland including radical prostatectomy, radiation therapy, and cryosurgery. Active surveillance is a growing alternative option for patients with documented low-volume, low-grade prostate cancer. With recent advances in software and hardware of MRI, multiparametric MRI of the prostate has been shown to improve the accuracy in detecting and characterizing clinically significant prostate cancer. Targeted biopsy is increasingly utilized to improve the yield of MR-detected, clinically significant prostate cancer and to decrease in detection of indolent prostate cancer. MR-guided targeted biopsy techniques include cognitive MR fusion TRUS biopsy, in-bore transrectal targeted biopsy using robotic transrectal device, and in-bore direct MR-guided transperineal biopsy with a software-based transperineal grid template. In addition, advances in MR compatible thermal ablation technology allow accurate focal or regional delivery of optimal thermal energy to the biopsy-proved, MRI-detected tumor, utilizing cryoablation, laser ablation, high-intensity focused ultrasound ablation under MR guidance and real-time or near simultaneous monitoring of the ablation zone. Herein we present a contemporary review of MR-guided targeted biopsy techniques of MR-detected lesions as well as MR-guided focal or regional thermal ablative therapies for localized naïve and recurrent cancerous foci of the prostate.

[1]  G. Onik,et al.  "Male lumpectomy": focal therapy for prostate cancer using cryoablation. , 2007, Urology.

[2]  A. Kawashima,et al.  Early localization of recurrent prostate cancer after prostatectomy by endorectal coil magnetic resonance imaging. , 2014, The Canadian journal of urology.

[3]  H. Kauczor,et al.  Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients , 2017, European Journal of Nuclear Medicine and Molecular Imaging.

[4]  Susanne Hempel,et al.  Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. , 2006, The Journal of urology.

[5]  R. Velthoven,et al.  A prospective clinical trial of HIFU hemiablation for clinically localized prostate cancer , 2015, Prostate Cancer and Prostatic Disease.

[6]  J. Pauly,et al.  Temperature quantitation and mapping of frozen tissue , 2001, Journal of magnetic resonance imaging : JMRI.

[7]  J M Dubernard,et al.  Transrectal high-intensity focused ultrasound: minimally invasive therapy of localized prostate cancer. , 2000, Journal of endourology.

[8]  M. Morrow,et al.  Five-Year Outcomes After Prostatectomy or Radiotherapy for Prostate Cancer: The Prostate Cancer Outcomes Study , 2006 .

[9]  E. Rummeny,et al.  11C-choline PET/CT and whole-body MRI including diffusion-weighted imaging for patients with recurrent prostate cancer , 2017, Oncotarget.

[10]  F A Jolesz,et al.  A clinical, noninvasive, MR imaging-monitored ultrasound surgery method. , 1996, Radiographics : a review publication of the Radiological Society of North America, Inc.

[11]  William P. Parker,et al.  Identification of Site-specific Recurrence Following Primary Radiation Therapy for Prostate Cancer Using C-11 Choline Positron Emission Tomography/Computed Tomography: A Nomogram for Predicting Extrapelvic Disease. , 2017, European urology.

[12]  Jan J W Lagendijk,et al.  MRI-guided robotic system for transperineal prostate interventions: proof of principle , 2010, Physics in medicine and biology.

[13]  B. Daniel,et al.  MRI‐guided cryoablation: In vivo assessment of focal canine prostate cryolesions , 2009, Journal of magnetic resonance imaging : JMRI.

[14]  A. Aschoff,et al.  Sensitivity of computed tomography in detecting local recurrence of prostatic carcinoma following radical prostatectomy. , 1997, The British journal of radiology.

[15]  Matthew R Cooperberg,et al.  Time trends and local variation in primary treatment of localized prostate cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Pierre Mozer,et al.  First round of targeted biopsies using magnetic resonance imaging/ultrasonography fusion compared with conventional transrectal ultrasonography‐guided biopsies for the diagnosis of localised prostate cancer , 2015, BJU international.

[17]  P. Scardino,et al.  Salvage therapy for locally recurrent prostate cancer after external beam radiotherapy , 2004, Current treatment options in oncology.

[18]  Scott B Reeder,et al.  Noninvasive temperature mapping with MRI using chemical shift water‐fat separation , 2010, Magnetic resonance in medicine.

[19]  A. Jemal,et al.  Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.

[20]  E. Bergstralh,et al.  Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years. , 2000, The Journal of urology.

[21]  Louis R Kavoussi,et al.  Accuracy of digital rectal examination and transrectal ultrasonography in localizing prostate cancer. , 1994, The Journal of urology.

[22]  Thomas Hambrock,et al.  Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. , 2011, Radiology.

[23]  R. Parker,et al.  Repeat Prostate Biopsy Strategies after Initial Negative Biopsy: Meta-Regression Comparing Cancer Detection of Transperineal, Transrectal Saturation and MRI Guided Biopsy , 2013, PloS one.

[24]  J. Fütterer,et al.  Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature. , 2015, European urology.

[25]  C. Ritch,et al.  Prostate cryotherapy: current status , 2009, Current opinion in urology.

[26]  Roger J. McNichols,et al.  Percutaneous MRI-guided laser thermal therapy in canine prostate , 2005, SPIE BiOS.

[27]  J. Witjes,et al.  Use of the Prostate Imaging Reporting and Data System (PI-RADS) for Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: A Diagnostic Meta-analysis. , 2015, European urology.

[28]  R. Clayman,et al.  In vitro, ex vivo and in vivo isotherms for renal cryotherapy. , 2010, The Journal of urology.

[29]  T. Uchida,et al.  High‐intensity focused ultrasound as salvage therapy for patients with recurrent prostate cancer after external beam radiation, brachytherapy or proton therapy , 2011, BJU international.

[30]  Kemal Tuncali,et al.  Transperineal in-bore 3-T MR imaging-guided prostate biopsy: a prospective clinical observational study. , 2015, Radiology.

[31]  Liangren Liu,et al.  Systematic Review and Meta-analysis of the Survival Outcomes of First-line Treatment Options in High-risk Prostate Cancer , 2015, Scientific Reports.

[32]  F. Beuvon,et al.  Detection of significant prostate cancer with magnetic resonance targeted biopsies--should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care? , 2015, The Journal of urology.

[33]  Kim Butts Pauly,et al.  Improved slice selection for R2* mapping during cryoablation with eddy current compensation , 2008, Journal of magnetic resonance imaging : JMRI.

[34]  V. Mouraviev,et al.  Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy , 2010, BJU international.

[35]  C. Stephan,et al.  Added Value of Multiparametric Ultrasonography in Magnetic Resonance Imaging and Ultrasonography Fusion-guided Biopsy of the Prostate in Patients With Suspicion for Prostate Cancer. , 2015, Urology.

[36]  B. Donnelly,et al.  Salvage prostate cryoablation: initial results from the cryo on-line data registry. , 2008, The Journal of urology.

[37]  William H. Nau,et al.  Referenceless MR Thermometry for Monitoring Thermal Ablation in the Prostate , 2007, IEEE Transactions on Medical Imaging.

[38]  S. Crouzet,et al.  Salvage high‐intensity focused ultrasound (HIFU) for locally recurrent prostate cancer after failed radiation therapy: Multi‐institutional analysis of 418 patients , 2017, BJU international.

[39]  J. Moul.  Prostate specific antigen only progression of prostate cancer. , 2000, The Journal of urology.

[40]  D. Siemens.  Radical prostatectomy or watchful waiting in early prostate cancer? , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[41]  M. Schostak,et al.  Eight years' experience with high-intensity focused ultrasonography for treatment of localized prostate cancer. , 2008, Urology.

[42]  C. Roy,et al.  Comparative sensitivities of functional MRI sequences in detection of local recurrence of prostate carcinoma after radical prostatectomy or external-beam radiotherapy. , 2013, AJR. American journal of roentgenology.

[43]  Jan J W Lagendijk,et al.  A new robotic needle insertion method to minimise attendant prostate motion. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[44]  Gerhard Adam,et al.  MR‐guided percutaneous cryotherapy of the liver: In vivo evaluation with histologic correlation in an animal model , 2001, Journal of magnetic resonance imaging : JMRI.

[45]  Jan van der Meulen,et al.  Multiparametric MR imaging for detection of clinically significant prostate cancer: a validation cohort study with transperineal template prostate mapping as the reference standard. , 2013, Radiology.

[46]  Ashok Gowda,et al.  MR thermometry‐based feedback control of laser interstitial thermal therapy at 980 nm , 2004, Lasers in surgery and medicine.

[47]  L. Kavoussi,et al.  In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12‐core biopsy still necessary in addition to a targeted biopsy? , 2015, BJU international.

[48]  S. Arora,et al.  Magnetic resonance-ultrasound fusion prostate biopsy in the diagnosis of prostate cancer. , 2016, Urologic oncology.

[49]  A. Partin,et al.  Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases. , 1994, Urology.

[50]  W. Dewey,et al.  Thermal dose determination in cancer therapy. , 1984, International journal of radiation oncology, biology, physics.

[51]  Akshay Bhandari,et al.  Vattikuti Institute prostatectomy, a technique of robotic radical prostatectomy for management of localized carcinoma of the prostate: experience of over 1100 cases. , 2004, The Urologic clinics of North America.

[52]  A. Jemal,et al.  Cancer Statistics, 2006 , 2006, CA: a cancer journal for clinicians.

[53]  S. Crouzet,et al.  Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients. , 2014, European urology.

[54]  J. Peabody,et al.  Salvage robotic‐assisted radical prostatectomy: initial results and early report of outcomes , 2009, BJU international.

[55]  A. Villers,et al.  Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review. , 2015, European urology.

[56]  Clare Allen,et al.  Is it time to consider a role for MRI before prostate biopsy? , 2009, Nature Reviews Clinical Oncology.

[57]  A. Stephenson,et al.  The value of radiotherapy in treating recurrent prostate cancer after radical prostatectomy , 2004, Nature Clinical Practice Urology.

[58]  Guy Vallancien,et al.  High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study. , 2003, Journal of endourology.

[59]  D. Ye,et al.  Re: Daher C. Chade, Shahrokh F. Shariat, Angel M. Cronin, et al. Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration. Eur urol 2011;60:205-10. , 2011, European urology.

[60]  J. Kepner,et al.  A biomedical engineering approach to mitigate the errors of prostate biopsy , 2012, Nature Reviews Urology.

[61]  Adam T Froemming,et al.  Prostate cancer post-treatment follow-up and recurrence evaluation , 2016, Abdominal Radiology.

[62]  Ken Muldrew,et al.  A semi-empirical treatment planning model for optimization of multiprobe cryosurgery. , 2000 .

[63]  A. Haese*,et al.  Inverse stage migration in patients undergoing radical prostatectomy: results of 8916 European patients treated within the last decade , 2011, BJU international.

[64]  C. Magi-Galluzzi,et al.  Saturation technique does not decrease cancer detection during followup after initial prostate biopsy. , 2008, The Journal of urology.

[65]  Thomas Hambrock,et al.  Three-Tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers. , 2012, European urology.

[66]  J. Jones.  Saturation biopsy for detecting and characterizing prostate cancer , 2007, BJU international.

[67]  Scott O. Quarrier,et al.  Salvage cryosurgery of the prostate for failure after primary radiotherapy or cryosurgery: long-term clinical, functional, and oncologic outcomes in a large cohort at a tertiary referral centre. , 2013, European urology.

[68]  R. Ghavamian,et al.  Minimally invasive approaches to prostate cancer: a review of the current literature. , 2007, Urology journal.

[69]  P. Carroll,et al.  Treatment failure after primary and salvage therapy for prostate cancer , 2008, Cancer.

[70]  Ian Young,et al.  The Feasibility of MR-Image Guided Prostate Biopsy Using Piezoceramic Motors Inside or Near to the Magnet Isocentre , 2006, MICCAI.

[71]  K. Vigen,et al.  In vivo MR thermometry of frozen tissue using R2* and signal intensity. , 2005, Academic radiology.

[72]  S. Silverman,et al.  MRI-guided percutaneous cryoablation of renal tumors: use of external manual displacement of adjacent bowel loops. , 2006, European journal of radiology.

[73]  R. Saskin,et al.  Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. , 2016, European urology.

[74]  J. Chapelon,et al.  Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer. , 2009, European urology.

[75]  J. Bomers,et al.  MR imaging-guided focal cryoablation in patients with recurrent prostate cancer. , 2013, Radiology.

[76]  P. Koutrouvelis,et al.  Salvage Reimplantation in Patient with Local Recurrent Prostate Carcinoma after Brachytherapy with Three Dimensional Computed Tomography-Guided Permanent Pararectal Implant , 2003, Technology in cancer research & treatment.

[77]  D. Downey,et al.  Results of salvage cryoablation of the prostate after radiation: identifying predictors of treatment failure and complications. , 2001, The Journal of urology.

[78]  Y. Yamada,et al.  Salvage brachytherapy for recurrent prostate cancer after definitive radiation therapy: A comparison of low-dose-rate and high-dose-rate brachytherapy and the importance of prostate-specific antigen doubling time. , 2017, Brachytherapy.

[79]  P. Scardino,et al.  Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. , 2005, International journal of radiation oncology, biology, physics.

[80]  G. Swanson,et al.  Salvage brachytherapy for localized prostate cancer after radiotherapy failure. , 1999, Urology.

[81]  Adam T Froemming,et al.  Detection of Local Recurrence of Prostate Cancer After Radical Prostatectomy Using Endorectal Coil MRI at 3 T: Addition of DWI and Dynamic Contrast Enhancement to T2-Weighted MRI. , 2015, AJR. American journal of roentgenology.

[82]  T. H. van der Kwast,et al.  EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. , 2014, European urology.

[83]  D. Grönemeyer,et al.  Accuracy of MRI-Targeted in-Bore Prostate Biopsy According to the Gleason Score with Postprostatectomy Histopathologic Control--a Targeted Biopsy-Only Strategy with Limited Number of Cores. , 2015, Academic radiology.

[84]  P. Walsh.  Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging. , 2005, The Journal of urology.

[85]  P. Maté Mate.  [Radical prostatectomy versus observation for localized prostate cancer]. , 2013, Revista clinica espanola.

[86]  Baris Turkbey,et al.  Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. , 2015, JAMA.

[87]  G. Glatting,et al.  [11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[88]  Fang-Ming Deng,et al.  Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes. , 2016, European urology.

[89]  Hessel Wijkstra,et al.  The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel , 2014, BJU international.

[90]  Baris Turkbey,et al.  What Are We Missing? False-Negative Cancers at Multiparametric MR Imaging of the Prostate. , 2018, Radiology.

[91]  Mark Emberton,et al.  Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. , 2013, European urology.

[92]  Shyam Natarajan,et al.  Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. , 2014, European urology.

[93]  H. Ahmed,et al.  Visually directed vs. software-based targeted biopsy compared to transperineal template mapping biopsy in the detection of clinically significant prostate cancer. , 2015, Urologic oncology.

[94]  P. Scardino,et al.  Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study , 2013, BMJ : British Medical Journal.

[95]  J. Weinreb,et al.  Standards for MRI reporting—the evolution to PI-RADS v 2.0 , 2017, Translational andrology and urology.

[96]  W. Cooner,et al.  Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. , 1990, The Journal of urology.

[97]  S. Shariat,et al.  Local recurrence after radical prostatectomy: correlation of US features with prostatic fossa biopsy findings. , 2001, Radiology.

[98]  C. Pashos,et al.  A nationwide charge comparison of the principal treatments for early stage prostate carcinoma , 2000, Cancer.

[99]  P. Carroll,et al.  Local recurrence after radical prostatectomy: characteristics in size, location, and relationship to prostate-specific antigen and surgical margins. , 1996, Urology.

[100]  M. Blute,et al.  Treatment of prostate cancer local recurrence after radical retropubic prostatectomy with 17-gauge interstitial transperineal cryoablation: initial experience. , 2007, Urology.

[101]  Michael C. Kolios,et al.  Magnetic resonance imaging of temperature changes during interstitial microwave heating: a phantom study. , 1997, Medical physics.

[102]  J. Felmlee,et al.  Feasibility of 3.0T magnetic resonance imaging-guided laser ablation of a cadaveric prostate. , 2010, Urology.

[103]  H. Ahmed,et al.  The feasibility and safety of high‐intensity focused ultrasound as salvage therapy for recurrent prostate cancer following external beam radiotherapy , 2008, BJU international.

[104]  V. Laudone,et al.  Reverse stage shift at a tertiary care center , 2011, Cancer.

[105]  R. Weersink,et al.  Real-time magnetic resonance imaging-guided focal laser therapy in patients with low-risk prostate cancer. , 2010, European urology.

[106]  A. D'Amico,et al.  Management of biochemical recurrence after primary treatment of prostate cancer: a systematic review of the literature. , 2013, European urology.

[107]  K. Kuroda,et al.  A precise and fast temperature mapping using water proton chemical shift , 1995, Magnetic resonance in medicine.

[108]  Ted Lee,et al.  Focal laser ablation for localized prostate cancer: principles, clinical trials, and our initial experience. , 2014, Reviews in urology.

[109]  J. Felmlee,et al.  Magnetic resonance imaging-guided cryoablation of recurrent prostate cancer after radical prostatectomy: initial single institution experience. , 2013, Urology.

[110]  Baris Turkbey,et al.  Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. , 2011, The Journal of urology.

[111]  J P Felmlee,et al.  An investigation of the effects from a urethral warming system on temperature distributions during cryoablation treatment of the prostate: a phantom study. , 2014, Cryobiology.

[112]  S. Barni,et al.  Radical prostatectomy or radiotherapy in high-risk prostate cancer: a systematic review and metaanalysis. , 2014, Clinical genitourinary cancer.

[113]  G. Haber,et al.  Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging‐targeted and systematic biopsy for significant prostate cancer detection , 2011, BJU international.

[114]  Adam T Froemming,et al.  Detection of Recurrent Prostate Cancer After Radical Prostatectomy: Comparison of 11C-Choline PET/CT with Pelvic Multiparametric MR Imaging with Endorectal Coil , 2014, The Journal of Nuclear Medicine.

[115]  J. Charboneau,et al.  MRI after technically successful renal cryoablation: early contrast enhancement as a common finding. , 2010, AJR. American journal of roentgenology.

[116]  John M Pauly,et al.  Referenceless PRF shift thermometry , 2004, Magnetic resonance in medicine.

[117]  L. Curiel,et al.  Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography. , 2004, Urology.

[118]  P. Pinto,et al.  Imaging modalities in focal therapy: patient selection, treatment guidance, and follow-up , 2014, Current opinion in urology.

[119]  J. Chapelon,et al.  Transrectal High Intensity Focused Ultrasound for the Treatment of Localized Prostate Cancer: Factors Influencing the Outcome , 2001, European Urology.

[120]  D. Kuban,et al.  Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era. , 2003, International journal of radiation oncology, biology, physics.

[121]  B. Daniel,et al.  MR imaging-guided percutaneous cryoablation of the prostate in an animal model: in vivo imaging of cryoablation-induced tissue necrosis with immediate histopathologic correlation. , 2009, Journal of vascular and interventional radiology : JVIR.

[122]  R. Stafford,et al.  Magnetic resonance guided, focal laser induced interstitial thermal therapy in a canine prostate model. , 2010, The Journal of urology.

[123]  A. Gangi,et al.  Percutaneous MR-guided cryoablation of prostate cancer: initial experience , 2012, European Radiology.

[124]  Shyam Natarajan,et al.  Prostate cancer detection with magnetic resonance‐ultrasound fusion biopsy: The role of systematic and targeted biopsies , 2016, Cancer.

[125]  T. Polascik,et al.  How to select the right patients for focal therapy of prostate cancer? , 2014, Current opinion in urology.

[126]  M. Terris,et al.  Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. , 1989, The Journal of urology.

[127]  Kimberly K Amrami,et al.  3.0T MR-guided laser ablation of a prostate cancer recurrence in the postsurgical prostate bed. , 2011, Journal of vascular and interventional radiology : JVIR.

[128]  Toyoaki Uchida,et al.  Improved outcomes with advancements in high intensity focused ultrasound devices for the treatment of localized prostate cancer. , 2015, The Journal of urology.

[129]  A. Gage,et al.  Mechanisms of tissue injury in cryosurgery. , 1998, Cryobiology.